Mary Zimmerman's Metamorphoses Flows Down Under and Across the U.S. | Playbill

Related Articles
News Mary Zimmerman's Metamorphoses Flows Down Under and Across the U.S. Though Mary Zimmerman's Broadway production of Metamorphoses closed Feb. 16 at the Circle in the Square Theatre, the play flows on to a number of regional productions including an Australian mounting.

Metamorphoses stages the great transformation myths of Ovid, with additional material compiled by Zimmerman from other sources, including the poet Rainer Maria Rilke. King Midas, Orpheus and Eurydice, and Cupid and Psyche all make appearances during the evening, wherein they change physically, emotionally and mentally. The play's most notable set piece is its 27-foot-wide rectangular pool. The first staging of the new work will play at the Melbourne Theatre Company in Australia, July 21-Aug. 30. (The production will boast a "ten-metre-wide pool.") Additional theatre across the United States have set their dates including The Repertory Theatre of St. Louis (Sept. 10-Oct. 10), Cincinnati Playhouse in the Park (Oct. 21-Nov. 21) and a co-production between Kansas City's Missouri Repertory Theatre (Jan. 23-Feb. 15, 2004) and Connecticut's Hartford Stage Company (Feb. 26-March 28, 2004).

Metamorphoses transferred to Broadway on Feb. 21, 2002, after a successful run at Off-Broadway's Second Stage. Following its March 4 Broadway opening, it won the Drama Desk, Drama League and Lucille Lortel prizes for Best Play and earned a Tony Award for Best Direction for director Zimmerman.

The Broadway run, which returned its entire investment of $1.7 million in a matter of months, was cut short as the production fell below the Circle in the Square Theatre's stop clause for two consecutive weeks during the month of December 2002.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!